Current schizophrenia drugs can quiet hallucinations and delusions, but the cognitive symptoms (disorganized thinking, memory problems, executive dysfunction) stay untreated. Those are the ones that ...

It’s a frustration for both doctors who treat patients with schizophrenia and for people living with it: the most effective antipsychotic drugs have side effects, so unpleasant patients would rather ...

A study has found a new biomarker of schizophrenia, which could also serve as a drug target for treating cognitive symptoms such as disorganised thinking or executive function. Schizophrenia is a ...

Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study ...

Researchers found that, compared with controls, intrinsic cellular age was slowed in schizophrenia cases in young adulthood, particularly in males, while phenotypic age was accelerated in later adults ...

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major advancement in schizophrenia treatment in decades. Unlike existing medications that ...

Doctors say early symptoms of schizophrenia don't always lead to severe illness - and that offers new hope for prevention.

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...

A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Researchers led by Markus ...

UCSF scientists are in a tight race against time, trying to spot telltale brain signals before a person’s first psychotic break. The idea is simple, even if the science is not: treat people while ...